• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯乙酰胺κ阿片受体激动剂U-50,488H对心脏钠通道具有强效且依赖使用的阻滞作用。

Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.

作者信息

Pugsley M K, Yu E J, Goldin A L

机构信息

Department of Microbiology & Molecular Genetics, University of California, Irvine, California, USA.

出版信息

Exp Clin Cardiol. 2001 Summer;6(2):61-71.

PMID:20428265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2859007/
Abstract

OBJECTIVES

To determine whether the kappa opioid receptor agonist U-50,488H, a benzacetamide derivative of the cyclo-hexane-1,2-diamine analgesics, may be a useful molecular probe to define the structural requirements of this class of drugs for cardiac sodium channel blockade.

ANIMALS AND METHODS

The electrophysiological effects of U-50,488H were compared with those of lidocaine, a clinically used class Ib antiarrhythmic agent, in rat heart sodium currents expressed in Xenopus laevis oocytes by using two-electrode voltage clamp.

RESULTS

Both U-50,488H and lidocaine produced a concentration-dependent tonic block of sodium current, but U-50,488H was approximately fourfold more potent than lidocaine. Both drugs produced a hyperpolarizing shift in the voltage dependence of sodium channel inactivation and both delayed recovery from inactivation. Both drugs exhibited use-dependent block, but U-50,488H showed a 1.8-fold increase in potency compared with lidocaine at a high frequency of stimulation (30 Hz).

CONCLUSIONS

The more potent tonic and use-dependent block of cardiac sodium channels by U-50,488H suggests that structural features of this molecule may provide it with a greater ability to block the channel. An understanding of these structural features may provide information needed in the development of novel arylacetamide-based antiarrhythmic drugs and insight into possible mechanisms describing channel block, resulting in a highly efficacious antiarrhythmic action in the heart.

摘要

目的

确定κ阿片受体激动剂U - 50,488H(一种环己烷 - 1,2 - 二胺镇痛药的苯乙酰胺衍生物)是否可能是一种有用的分子探针,以界定这类药物对心脏钠通道阻滞的结构要求。

动物与方法

通过双电极电压钳技术,在非洲爪蟾卵母细胞中表达的大鼠心脏钠电流上,比较U - 50,488H与临床使用的Ib类抗心律失常药物利多卡因的电生理效应。

结果

U - 50,488H和利多卡因均产生浓度依赖性的钠电流强直阻滞,但U - 50,488H的效力约为利多卡因的四倍。两种药物均使钠通道失活的电压依赖性发生超极化偏移,且均延迟失活后的恢复。两种药物均表现出使用依赖性阻滞,但在高频刺激(30 Hz)下,U - 50,488H的效力比利多卡因高1.8倍。

结论

U - 50,488H对心脏钠通道更有效的强直和使用依赖性阻滞表明,该分子的结构特征可能使其具有更强的通道阻滞能力。了解这些结构特征可能为新型芳基乙酰胺类抗心律失常药物的开发提供所需信息,并深入了解描述通道阻滞的可能机制,从而在心脏中产生高效的抗心律失常作用。

相似文献

1
Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.苯乙酰胺κ阿片受体激动剂U-50,488H对心脏钠通道具有强效且依赖使用的阻滞作用。
Exp Clin Cardiol. 2001 Summer;6(2):61-71.
2
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.κ-阿片受体激动剂U-50,488H抗心律失常作用的电生理基础。
Eur J Pharmacol. 1994 Aug 22;261(3):303-9. doi: 10.1016/0014-2999(94)90121-x.
3
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.新型 I 类抗心律失常药物比沙胺对心脏、骨骼肌和脑钠通道的作用。
Eur J Pharmacol. 1998 Jan 19;342(1):93-104. doi: 10.1016/s0014-2999(97)01420-9.
4
Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes.螺旋多林是一种κ阿片受体激动剂,可对非洲爪蟾卵母细胞中表达的钠通道产生强直性和使用依赖性阻断。
Gen Pharmacol. 2000 Jun;34(6):417-27. doi: 10.1016/s0306-3623(01)00079-9.
5
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.U-50488H,一种κ阿片受体激动剂,是一种比利多卡因更强效的心脏钠通道阻滞剂。
Proc West Pharmacol Soc. 2000;43:47-50.
6
Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.κ-激动剂U-50,488H在有无阿片受体阻断情况下的心血管作用
Br J Pharmacol. 1992 Mar;105(3):521-6. doi: 10.1111/j.1476-5381.1992.tb09012.x.
7
Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.κ受体激动剂spiradoline的钠通道阻滞特性是其在大鼠体内抗心律失常作用的原因。
J Cardiovasc Pharmacol. 1998 Dec;32(6):863-74. doi: 10.1097/00005344-199812000-00002.
8
Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.慢性联合应用二氢吡啶对豚鼠回肠中κ-阿片受体介导的耐受性的调节作用。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Jun;354(1):72-9. doi: 10.1007/BF00168709.
9
Meperidine and lidocaine block of recombinant voltage-dependent Na+ channels: evidence that meperidine is a local anesthetic.哌替啶和利多卡因对重组电压依赖性钠通道的阻断作用:哌替啶是局部麻醉药的证据。
Anesthesiology. 1999 Nov;91(5):1481-90. doi: 10.1097/00000542-199911000-00042.
10
Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.U50,488H对缺血/再灌注大鼠心脏的心脏保护和抗心律失常作用。
Heart Vessels. 2007 Sep;22(5):335-44. doi: 10.1007/s00380-007-0983-z. Epub 2007 Sep 20.

引用本文的文献

1
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.基于阿片受体激动剂的心脏保护和抗心律失常药物的研发前景
Med Res Rev. 2016 Sep;36(5):871-923. doi: 10.1002/med.21395. Epub 2016 May 16.

本文引用的文献

1
A quantitative description of membrane current and its application to conduction and excitation in nerve.膜电流的定量描述及其在神经传导和兴奋中的应用。
J Physiol. 1952 Aug;117(4):500-44. doi: 10.1113/jphysiol.1952.sp004764.
2
Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.美西律结构的分子决定因素对骨骼肌钠通道的强效和使用依赖性阻断作用
Mol Pharmacol. 2000 Feb;57(2):268-77.
3
A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel.钠通道静息状态与开放和失活状态下不同局部麻醉药亲和力的分子基础。
Mol Pharmacol. 1999 Jan;55(1):134-41. doi: 10.1124/mol.55.1.134.
4
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.新型 I 类抗心律失常药物比沙胺对心脏、骨骼肌和脑钠通道的作用。
Eur J Pharmacol. 1998 Jan 19;342(1):93-104. doi: 10.1016/s0014-2999(97)01420-9.
5
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.局部麻醉药、抗心律失常药和抗惊厥药对电压门控性Na+通道阻滞的常见分子决定因素。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9270-5. doi: 10.1073/pnas.93.17.9270.
6
Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels.心脏钠通道(hH1)本质上比骨骼肌(mu 1)通道对利多卡因的阻断更敏感。
J Gen Physiol. 1995 Dec;106(6):1193-209. doi: 10.1085/jgp.106.6.1193.
7
Distinct local anesthetic affinities in Na+ channel subtypes.钠通道亚型中不同的局部麻醉药亲和力。
Biophys J. 1996 Apr;70(4):1700-8. doi: 10.1016/S0006-3495(96)79732-1.
8
Use-dependent inhibition of Na+ currents by benzocaine homologs.苯佐卡因同系物对钠离子电流的使用依赖性抑制作用。
Biophys J. 1996 Jan;70(1):194-201. doi: 10.1016/S0006-3495(96)79563-2.
9
Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp.化学与生物学中的阳离子-π相互作用:对苯、苯丙氨酸、酪氨酸和色氨酸的新认识。
Science. 1996 Jan 12;271(5246):163-8. doi: 10.1126/science.271.5246.163.
10
Quaternary ammonium derivative of lidocaine as a long-acting local anesthetic.
Anesthesiology. 1995 Dec;83(6):1293-301. doi: 10.1097/00000542-199512000-00020.